25.04.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics...
25.10.2012
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a biologics contract manufacturing agreement with...
23.10.2012
- Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of a new non-executive director to Cobra...
06.10.2012
- The Obama administration's reluctance to push for 12 years of data protection on "biologic" medicines in free-trade talks is a growing concern for U.S. drug manufacturers who...
18.07.2012
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first...
31.10.2011
- Swiss drugs industry supplier Lonza is set to grow underlying sales and operating profit this year despite the strong Swiss franc as it benefits from robust demand from...
10.03.2010
- Facet Biotech has agreed to be acquired by Abbott Laboratories for $27 a share, topping a hostile offer of $17.50 a share made last year by Biogen Idec. Shares of Facet rose 67%...
08.03.2010
- Wacker Chemie has opened a new production facility for pharmaceutical proteins - also known as biologics - in Jena, Germany. The new plant is part of the Munich-based chemical...
